Investment and Startups

Evogene to Receive $3.5 million Payment Related to Patent Portfolio under its Existing Seed Traits Collaboration with Bayer

Share this

10 December 2022, Israel: Evogene Ltd., a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, announced today that Bayer will pay Evogene an amount of $3.5 million under their joint seed traits collaboration agreement.

Under the collaboration agreement, Evogene provided Bayer with a license to genes discovered to address specific seed traits, for use in corn, soy, cotton, and canola. The payment is part of a restructuring of the patent filing, prosecution, and maintenance obligations under the collaboration.

Also Read: World Soil Day 2022: FAO publishes first global report on black soils

(For Latest Agriculture News & Updates, follow Krishak Jagat on Google News)

Share this